Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Head/Neck Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03585673
What this trial is testing

Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal Carcinoma

Who this might be right for
Esophagus Squamous Cell Carcinoma (SCC)Metastatic Cancer
Sung Yong Oh 38
Not applicableLooking for participantsNCT07088354
What this trial is testing

Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant ImmunochemotherapyPathological Complete Response+1 more
Tongji Hospital 300
Not applicableStudy completedNCT06244394
What this trial is testing

Retrospective Study on the Prediction of Radiation-induced Brain Injury in Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRadiation-Induced Temporal Lobe Injury
Jiangsu Cancer Institute & Hospital 230
Testing effectiveness (Phase 2)Active Not RecruitingNCT05659251
What this trial is testing

Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 48
Large-scale testing (Phase 3)Study completedNCT00002631
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Radiation Therapy Oncology Group 298
Early research (Phase 1)Ended earlyNCT03991741
What this trial is testing

Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors

Who this might be right for
Metastatic MelanomaLocally Advanced Refractory/Recurrent MelanomaMetastatic Head and Neck Cancer+1 more
Gregory Daniels 3
Not applicableLooking for participantsNCT06443866
What this trial is testing

I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer

Who this might be right for
Thyroid CancerRAI-Refractory Thyroid Cancer
Miami Cancer Research Center, Inc. 50
Early research (Phase 1)Enrolling By InvitationNCT07218003
What this trial is testing

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Who this might be right for
Non Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more
Rondo Therapeutics 149
Not applicableLooking for participantsNCT06792786
What this trial is testing

Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

Who this might be right for
Esophageal CancerctDNA
The Central Hospital of Lishui City 30
Testing effectiveness (Phase 2)Ended earlyNCT04844073
What this trial is testing

TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Who this might be right for
Squamous Cell Cancer of Head and Neck (SCCHN)Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer
Takeda 95
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07303283
What this trial is testing

Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Locoregionally Advanced Nasopharyngeal CarcinomaAdjuvant Therapy
Kai Hu 140
Not applicableStudy completedNCT00875953
What this trial is testing

Use of the Harmonic Scalpel in Neck Dissection

Who this might be right for
Neck Dissection
University of Calgary 34
Testing effectiveness (Phase 2)UnknownNCT04586088
What this trial is testing

Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure

Who this might be right for
Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+3 more
Sun Yat-sen University 58
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Not applicableLooking for participantsNCT06979869
What this trial is testing

Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma

Who this might be right for
Esophageal Cancer
Xijing Hospital 300
Not applicableStudy completedNCT01392222
What this trial is testing

Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others

Who this might be right for
Thyroid CancerPapillary Microcarcinoma
Memorial Sloan Kettering Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT02684253
What this trial is testing

Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Memorial Sloan Kettering Cancer Center 65
Testing effectiveness (Phase 2)Study completedNCT06446570
What this trial is testing

Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma

Who this might be right for
HNSCCHead and Neck Neoplasms
Seoul National University Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT02901483
What this trial is testing

PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
PharmaEngine 12
Testing effectiveness (Phase 2)Study completedNCT00389441
What this trial is testing

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Pfizer 52
Next Page